63USE IN CLINICAL PRACTICE
Italian consensus conference (CC) on guidelines on conservative treatment on lower limb muscle injuries in athlete:[Bisciotti 2018]
The CC presented a clear overview of the state of the art of pharmacological and instrumental therapy concerning muscle injury.
The CC considered Traumeel®, marketed in Italy as ointment, tablets, drops and ampoules for injection.
It is noted that in the literature, there are randomized controlled trials that show its efficacy in the reduction of pain and swelling following muscle injuries.
They also noted that Traumeel® has proven to be well-tolerated with little adverse effects.
The CC hopes that further evidence in the future will confirm its therapeutic validity.
A consensus document issued by the Spanish Federation of Sports Medicine (FEMEDE) on injectable therapies aims to improve patient quality of care and assist in making therapeutic decisions:[Del Valle Soto 2013]
The level of scientific evidence that supports the use of bioregulatory drugs (particularly Traumeel®) can be considered acceptable and there is a growing literature supporting use.
Therefore, injectable biologic therapies are an alternative in the treatment of sports injuries and their effects are comparable to those of other drugs and usually have no side effects.
Components of bioregulatory therapy can modulate inflammation and injury symptoms, they are analgesic, stimulate healing and may have hemostatic effects contributing to eliminate edema and venous stasis.
Their ultimate goal is to restore the normal functioning of the regulatory mechanisms.
The choice of the injectable route will depend on the type of pathology, the injury severity, the patient s general condition and also the clinical experience of the prescribing physician.
These injectable therapies can be administered alone, associated with each other or with other medicines or techniques.
The increasing level of scientific evidence demonstrates that bioregulatory therapies in the treatment of sports injuries and their effects are comparable to those of other drugs, including NSAIDs, and have a favorable safety profile.
Spanish Consensus Statement: The Treatment of Muscle Tears in Sport:[Fernandes Jaen 2016]
Experts from the Spanish Society for Sports Traumatology and FEMEDE developed a consensus document to consider the most appropriate actions to be taken when treating muscle tears, based on proven scientific data.
The sports traumatology experts considered four differentiated phases during muscle repair: inflammatory; degenerative and vascularization; cell-stimulating, proliferative, and fibrotic; and the remodeling phase.
The recommendations concluded that anti-inflammatory administration must be avoided since it greatly affects biochemical reactions present in inflammation, thus causing muscle recovery to slow down
